A comparative evaluation of timolol maleate and pilocarpine in the treatment of chronic open angle glaucoma

Eye (Basingstoke)

Volumn 2, Issue 3, 1988, Pages 243-249

  Dallas, N L ^a   Sponsel, W E ^a   Hobley, A J ^a  

^a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PILOCARPINE; TIMOLOL MALEATE;

GLAUCOMA; HUMAN; MAJOR CLINICAL STUDY; OPEN ANGLE GLAUCOMA; TOPICAL DRUG ADMINISTRATION;

AGED; CLINICAL TRIALS; COMPARATIVE STUDY; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMAN; MALE; MIDDLE AGE; PERIMETRY; PILOCARPINE; TIMOLOL; TONOMETRY;

EID: 0023722356     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.1988.49     Document Type: Article

References (17)

1. Sponsel WE, Hobley AJ, Dallas NL, Henson DB. Visual field survival; a comparison of the effects of pilocarpine and timolol in open angle glaucoma. Proc XXV Int Cong Ophthal Glaucoma Society. In; New Trends in Ophthalmology (CIC, Roma) 1986; In Press.
2. Sponsel WE, Hobley, AJ, Williams AH, Dallas NL. Glaucoma assessment by microcomuter. Trans Ophthalmol Soc UK 1984; 104: 100-5.
3. Sponsel WE, Dallas NL, Burbridge L. Visual field survival: the response to timolol therapy in open-angle glaucoma. Br J Ophthalmol 1983; 67: 220-7.
4. Henson DB, Dix SM. Evaluation of the Friedman Visual Field Analyser Mark II. Part 2. Results from a population with induced visual field defects. Br J Ophthalmol 1984; 68: 463-7.
5. Sponsel WE, Williams AH, Dallas NL, Henson DB. A microcomputer-based glaucoma assessment system for clinical ophthalmologists. Res and Clin Forums 1983; 5: 2535.
6. Leibowitz HM et al. The Framingham Study Monograph, Section IV. Glaucoma. Surv Ophthalmol 1980; 24: 336-76.
7. Hollows FC, Graham PA. Intraocular pressure, glaucoma, and glaucoma suspects in a defined population. Br J Ophthalmol 1966; 50: 570-86.
8. Holmin C, Krakau CET. Regression analysis of the central visual field in chronic glaucoma cases. Acta Oph/ia/mo/1982; 60: 267-74.
9. Krakau CET. Visual field decay in chronic glaucoma. In Glaucoma Update II (Kriegls-tein GK, Leydhecker W, eds) Springer Verlag 1983; 123-8.
10. Flammer J, Drance S. The effect of a number of glaucoma medications on differential light threshold. Doc Ophthalmol Proc Series 1983; 35: 145-55.
11. Helman K. Progression and regression of visual field defects. In Glaucoma: Conceptions of a Disease (Heilman K, Richardson KT, eds) George Theime Pub, Stuttgart, 1978; 168-75.
12. Heijl A, Bengtsson B. Does laser-induced reduction of intraocular pressure improve the glaucomatous visual field? Ac Ophthalmol 1984; 62: 705-14.
13. Kidd MA, O’Conner M. Progression of field loss after trabeculectomy: a five-year followup. Br J Ophthalmol 1985; 69: 827-31.
14. Daubs J, Crick RP. Epidemiological analysis of King’s College Hospital glaucoma data. Res & Clin Forums 1980; 2: 41-59.
15. Ernest JT, Goldstick TK. Timolol maleate and choroidal blood flow. Glaucoma Update II (Krieglstein GK, Leydhecker W, eds) Springer Verlag 1983;45-50.
16. Grunwald J. Laser doppler velocimetric study of the effect of topical timolol on the normal human retinal circulation. Proc XXV Int Cong Ophthalmol Glaucoma Society, In New Trends in Ophthalmology (CIC, Roma) 1986; (In Press).
17. Henson DB. Intraocular pressure n glaucoma screening. The Optician, Sept 14, 1984; 10-12.